US FDA approves Glaukos' new eye therapy

The U.S. Food and Drug Administration has approved a new eye therapy from Glaukos Corp , giving patients a less painful and more convenient option to treat a progressive condition that can severely ...
Healio

FDA approves Epioxa for keratoconus

Epioxa is the first epithelium-on cross-linking procedure approved in the U.S. Glaukos plans for Epioxa to be commercially ...
Ophthalmology Times

Glaukos receives FDA approval for Epioxa topical therapy for keratoconus

Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for keratoconus. 1,2 This approval makes it the first FDA-approved corneal ...
Ophthalmology Times

AAO 2025: Understanding and diagnosing endophthalmitis

At the 2025 annual meeting of the American Academy of Ophthalmology, Sunir J. Garg, MD, gave a presentation titled, "Endophthalmitis Sterile or not." In an interview with Ophthalmology Times, he ...